New benzimidazole derivatives as antihistamine agents

一种化合物、烷基的技术,应用在新型苯并咪唑衍生物领域,能够解决缺乏活性等问题

Active Publication Date: 2017-08-29
FAES FARMA SA
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The present invention relates to a group of novel compounds with benzimidazole structure, which have effective selective H 1 Antihistamine activity, lack of activity on the central nervous system and cardiovascular system

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New benzimidazole derivatives as antihistamine agents
  • New benzimidazole derivatives as antihistamine agents
  • New benzimidazole derivatives as antihistamine agents

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0102] Example 1. Synthesis of 2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethan-1-ol

[0103]

[0104] 2-Ethoxyethyl 4-methylbenzenesulfonate (2.4 g, 9.7 mmol) and KOH (0.71 g, 13 mmol) were added to 2-(4-(1H-benzo[d]imidazol-2-yl )piperidin-1-yl)ethan-1-ol (Intermediate A, 1.6 g, 5.1 mmol) in 10 ml of DMF. The reaction was heated to 40-45°C with stirring for 5-6 hours. Water (15ml) was added, and the mixture was washed with CH 2 Cl 2 (3 x 10ml) extraction. The organic layer was dried over anhydrous sodium sulfate, and the solvent was evaporated in vacuo to give an oil, which was subjected to flash chromatography (DCM / CH 3 OH 95:5) to afford 1 g (61.9% yield) of 2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazole-2- base) piperidin-1-yl) ethan-1-ol. 1 H-NMR (CDCl 3)7.7(m,1H),7.3-7.2(m,3H),4.3(t,2H),3.7(m,4H),3.4(c,2H),3.3-3.1(m,4H),2.7(m ,2H), 2.5(m,2H), 2.3-2.1(m,4H), 1.1(t,3H)ppm.

Embodiment 2

[0105] Example 2. 2-(1-(2-(2-ethoxyethoxy)ethyl)piperidin-4-yl)-1-(2-ethoxyethyl)-1H-benzo[ d] imidazole

[0106] In the same experiment as in Example 1 above, 0.3 g (15% yield) of the compound of Example 2 was also obtained in the form of a yellow oil. 1 H-NMR (CDCl 3 )7.7(m,1H),7.3-7.2(m,3H),4.3(t,2H),3.7(m,4H),3.4(c,2H),3.3-3.1(m,4H),2.7(m ,2H), 2.5(m,2H), 2.3-2.1(m,4H), 1.1(t,3H)ppm.

Embodiment 3

[0108] Example 3. 3-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)propan-1-ol. From the middle Body B and 2-ethoxyethyl 4-methylbenzenesulfonate

[0109]

[0110] 1 H-NMR (CDCl 3 ):7.7(m,1H),7.3-7.2(m,3H),4.3(t,2H),3.8(t,2H),3.7(t,2H),3.9(s,1H),3.4(q, 2H), 3.3(m, 2H), 3.0(m, 1H), 2.7(m, 2H), 2.2(m, 4H), 2.0(m, 2H), 1.8(m, 2H), 1.1(t, 3H )ppm.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof, a method of synthesis of said compounds, pharmaceutical compositions comprising them and their use in the treatment and / or prevention of conditions mediated by H1 histamine receptor, such as allergic disorders or diseases.

Description

technical field [0001] The present invention relates to novel benzimidazole derivatives, methods of synthesis, pharmaceutical compositions containing them and their use as antihistamine and antiallergic agents. Background technique [0002] It has long been known that histamine plays a very important role in allergic diseases such as allergic rhinitis, conjunctivitis, rhinoconjunctivitis, dermatitis, urticaria and asthma. Histamine H 1 - Antihistamine compounds acting at the receptor level are used to treat such symptoms. [0003] The first generation H 1 Antihistamines produce many adverse effects due to their effects on the central nervous system and cholinergic receptors. [0004] The search for molecules that do not cross the blood-brain barrier has led to the replacement of earlier antihistamines by other second-generation antihistamines that overcome the side effects associated with their effects on the central nervous system. More recently, this new generation of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/14C07D401/04C07D471/04A61K31/454A61K31/4545A61P11/02A61P11/06A61P17/00A61P37/08A61P27/02
CPCC07D401/04C07D401/14C07D471/04A61K31/4184A61K31/437A61K31/454A61P11/02A61P11/06A61P17/00A61P17/04A61P27/02A61P27/14A61P29/00A61P37/08A61P43/00
Inventor 罗萨·罗德斯·索拉内斯罗伯托·奥利韦拉·蒂兹内贡萨洛·埃尔南德斯·埃雷罗维克多·鲁维奥·罗约弗朗西斯科·莱多·戈麦斯
Owner FAES FARMA SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products